Global Cell Analysis Market, By Product (Flow Cytometry Products, Qpcr Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, High-Content Screening Systems, Other Products), Process (Cell Identification, Cell Viability, Cell Signalling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, Single-Cell Analysis), End User (Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROS), Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, Other End Users) – Industry Trends and Forecast to 2030.
Cell Analysis Market Analysis and Size
According to the American Cancer Society, cancer is the second leading cause of death in the United States, trailing only heart disease. According to cancer statistics, 1.9 million new cancer cases are expected in the United States in 2022. Thus, the rising prevalence of cancer, as well as the never-ending research and development in this field, are expected to have a positive impact on industry growth.
Data Bridge Market Research analyses that the cell analysis market which is USD 18.41 billion in 2022, is expected to reach USD 33.82 billion by 2030, at a CAGR of 7.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cell Analysis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Flow Cytometry Products, Qpcr Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, High-Content Screening Systems, Other Products), Process (Cell Identification, Cell Viability, Cell Signalling Pathway/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Cell Structure Study, Target Identification and Validation, Single-Cell Analysis), End User (Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROS), Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, Other End Users)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), General Electric (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc (U.S.), Olympus Corporation (Japan), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Tecan Trading AG (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), BioStatus Limited (U.K.), NanoCellect Biomedical (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Cell analysis is an umbrella term for a wide range of technologies used to study a cell's genetic and phenotypical characteristics. Its goal is to gain insights into the mechanisms of cellular functionality, which necessitates an understanding of cellular components such as DNA, RNA, protein content, and cellular metabolites. Cell analysis is commonly used to understand population heterogeneity, identify minority subpopulations of interest, and discover unique characteristics of individual cells. It also helps with gene and protein identification, epigenomics, and understanding the factors that govern cell health, proliferation, and death.
Cell Analysis Market Dynamics
Drivers
- Growing demand for analytical tools
The increasing demand for analytical tools for innovative research and subsequent funding has resulted in the introduction of high-throughput equipment. Multiple innovations have led to this equipment incorporating features such as automation, high sensitivity, and accuracy, all of which aid in the analysis of scarce samples. For instance, Deepcell Inc., a U.S.-based company, received USD 73 million in funding in March 2022 to accelerate and commercialize its AI-powered single cell analysis platform. As a result, key players are significantly investing in developing solutions, resulting in a lucrative revenue generation opportunity in the coming years.
Opportunities
- Technological advancements in cell analysis
The rising prevalence of chronic diseases and the development of advanced cancer therapies are driving technological advancements in cell analysis. For instance, Fluidigm Corporation, based in the United States, announced the launch of a REAP-seq (RNA expression and protein sequencing) platform that will aid researchers in understanding the mechanisms of cancer progression and immune response.
Restraints/Challenges
- High cost associated with instruments
Large costs associated with the use of instruments and complex and time-consuming guidelines will be some of the constraints that will hamper the cell analysis during the forecast period. The greatest challenge to the market's growth will be a lack of skilled professionals.
This cell analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2022, Lifebit, a big data company based in the United Kingdom, announced a partnership with Boehringer Ingelheim. The collaboration will use Lifebit's Cloud OS, the first federated genomics platform, to build a data analytics infrastructure for Boehringer. This infrastructure will collect disease insights from biobanks in order to develop medicines.
- In 2021, SeqWell Inc. announced the release of the plexWell Single Cell Rapid Kit. The kit can be used for single-cell RNA sequencing as well as simplified NGS library preparation.
Global Cell Analysis Market Scope
The cell analysis market is segmented on the basis of product, process and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Flow Cytometry Products
- Reagents and Consumables
- Instruments
- Accessories
- Software
- Qpcr Products
- Reagents and Consumables
- Instruments
- Cell Microarrays
- Consumables
- Instruments
- Microscopes
- Electron Microscopes
- Inverted Microscopes
- Stereo Microscopes
- Fluorescence and Confocal Microscopes
- Phase-Contrast Microscopes
- Near-Field Scanning Optical Microscopes
- Other Microscopes
- Spectrophotometers
- Single-Mode Readers
- Multi-Mode Readers
- Cell Counters
- Automated Cell Counters
- Hemocytometers
- Manual Cell Counters
- High-Content Screening Systems
- Other Products
Process
- Cell Identification
- Cell Viability
- Cell Signalling Pathway/Signal Transduction
- Cell Proliferation
- Cell Counting and Quality Control
- Cell Interaction
- Cell Structure Study
- Target Identification and Validation
- Single-Cell Analysis
End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROS)
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Cell Culture Collection Repositories
- Other End Users
Cell Analysis Market Regional Analysis/Insights
The cell analysis market is analyzed and market size insights and trends are provided by country, product, process and end user as referenced above.
The countries covered in the cell analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the cell analysis market because of the prevalence of the business environment, increased government investment in drug discovery, and an increase in the number of research activities in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The cell analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cell analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell analysis market. The data is available for historic period 2011-2021.
Competitive Landscape and Cell Analysis Market Share Analysis
The cell analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cell analysis market.
Some of the major players operating in the cell analysis market are:
- Danaher (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- BD (U.S.)
- General Electric (U.S.)
- Merck KGaA (Germany)
- Agilent Technologies, Inc (U.S.)
- Olympus Corporation (Japan)
- Promega Corporation (U.S.)
- PerkinElmer Inc. (U.S.)
- Tecan Trading AG (Switzerland)
- Miltenyi Biotec (Germany)
- Carl Zeiss AG (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Sysmex Corporation (Japan)
- BioStatus Limited (U.K.)
- NanoCellect Biomedical (U.S.)
SKU-